Back to User profile » Dr Gang Wang

Papers published by Dr Gang Wang:


Effectiveness and Safety of Vortioxetine for Major Depressive Disorder in Real-World Clinical Practice: Results from the Single-Arm RELIEVE China Study

Wang G, Xiao L, Ren H, Simonsen K, Ma J, Xu X, Guo P, Wang Z, Bai L, Heldbo Reines E, Hammer-Helmich L

Neuropsychiatric Disease and Treatment 2022, 18:1939-1950

Published Date: 30 August 2022

Definition and Identification of Patients with Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia

Han C, Wang G, Chan S, Kato T, Ng CH, Tan W, Zhang L, Feng Y, Liu CY

Neuropsychiatric Disease and Treatment 2020, 16:2929-2941

Published Date: 3 December 2020

Management of Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia

Wang G, Han C, Liu CY, Chan S, Kato T, Tan W, Zhang L, Feng Y, Ng CH

Neuropsychiatric Disease and Treatment 2020, 16:2943-2959

Published Date: 3 December 2020

Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China

Wang G, Si TM, Li L, Fang Y, Wang CX, Wang LN, Tan KHX, Ettrup A, Eriksen HLF, Luo S, Ge L

Neuropsychiatric Disease and Treatment 2019, 15:1723-1736

Published Date: 1 July 2019

Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety

Wang G, You X, Wang X, Xu X, Bai L, Xie J, Yao Z, Yi Q, Ma J, Wang J, Zhuo J, Hu C

Neuropsychiatric Disease and Treatment 2018, 14:2087-2097

Published Date: 14 August 2018

Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study

Savitz AJ, Xu H, Gopal S, Nuamah I, Ravenstijn P, Hough D, Mathews M, Feng Y, Yu L, Takahashi M, Liu D, Wang G, Yoon J, Chen JJ

Neuropsychiatric Disease and Treatment 2017, 13:2193-2207

Published Date: 17 August 2017